Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-01-29 @ 4:06 PM
Study NCT ID:
NCT05082259
Status:
RECRUITING
Last Update Posted:
2025-05-20
First Post:
2021-10-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab
Sponsor:
Institute of Cancer Research, United Kingdom
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CCR5199
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None